Compare DexCom, Inc. (DXCM) vs T Rowe Price Group Inc (TROW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs T Rowe Price Group Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while T Rowe Price Group Inc trades at $116.99 (market cap $24.26B). The key difference: DexCom, Inc. is the larger of the two by market cap, and T Rowe Price Group Inc pays a 4.57% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | TROW | |
|---|---|---|
Market Cap | $33.79B | $24.26B |
Sector | Health | Financials |
52-Week High | $89.53 | $121.68 |
52-Week Low | $54.84 | $86.19 |
Enterprise Value | $33.24B | $21.46B |
Dividend Yield | — | 4.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About T Rowe Price Group Inc
T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.
Read more on TROW →
